Welcome to LookChem.com Sign In|Join Free
  • or
ethyl 3-(2-chlorophenyl)-2-(diethoxyphosphoryl)propanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

866028-25-3

Post Buying Request

866028-25-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

866028-25-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 866028-25-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,6,0,2 and 8 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 866028-25:
(8*8)+(7*6)+(6*6)+(5*0)+(4*2)+(3*8)+(2*2)+(1*5)=183
183 % 10 = 3
So 866028-25-3 is a valid CAS Registry Number.

866028-25-3Relevant academic research and scientific papers

Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors

Cocco, Mattia,Miglio, Gianluca,Giorgis, Marta,Garella, Davide,Marini, Elisabetta,Costale, Annalisa,Regazzoni, Luca,Vistoli, Giulio,Orioli, Marica,Massulaha-Ahmed, Ra?hane,Détraz-Durieux, Isabelle,Groslambert, Marine,Py, Bénédicte F.,Bertinaria, Massimo

, p. 1790 - 1803 (2016)

NLRP3 inflammasome plays a key role in the intracellular activation of caspase-1, processing of pro-inflammatory interleukin-1β (IL-1β), and pyroptotic cell death cascade. The overactivation of NLRP3 is implicated in the pathogenesis of autoinflammatory d

ALPHA-(ARYL-OR HETEROARYL-METHYL)-BETA-PIPERIDINOPROPANOIC ACID COMPOUNDS AS ORL1-RECEPTOR ANTAGONISTS

-

Page/Page column 34, (2010/11/25)

This invention provides the compounds of formula (I): or a pharmaceutically acceptable ester or salt thereof, wherein R1 and R2 independently represent hydrogen or the like; R3 represents aryl or the like; -X-Y- represents

ALPHA ARYL OR HETEROARYL METHYL BETA PIPERIDINO PROPANAMIDE COMPOUNDS AS ORL1-RECEPTOR ANTAGONIST

-

Page/Page column 90, (2010/02/14)

This invention provides the compounds of formula (I): or a pharmaceutically acceptable ester of such compound, or a pharmaceutically acceptable salt thereof, wherein Ri and R2 independently represent a hydrogen atom or the like; R3 represents a hydrogen atom, or the like; R4 represents a hydrogen atom or the like; (formula II) represents one of the following or the like; R5 represents an aryl group having from 6 to 10 ring atoms or the like; X represents an oxygen atom, or the like; Y represents an oxgen atom or the like and n represents an integer 0, 1 or 2. These compounds have ORL1-receptor antagonist activity; and therefore, are useful to treat diseases or conditions such as pain, various CNS diseases etc.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 866028-25-3